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ABSTRACT
Objective: Needle exchange programs are designed to educate injection
drug users of healthy drug behaviors and establish a controlled environment to
prevent blood-borne diseases through clean needles and provide treatment to
reduce blood-borne diseases and become drug-free. This study observed the
prevalence of blood-borne diseases among injection drug users as well as the
general population. The study used publicly available data of drug use to assess
differences by race/ethnicity, and participation in needle exchange programs.
Methods: Quantitative methods were used with the 2019 National Survey
on Drug Use and Health. Analysis began with descriptive statistics, followed by
regression analyses to understand the association between (1) injection drug use
and HIV/AIDs, (2) involvement in needle exchange programs and HIV/AIDs
among injection drug users, and (3) race/ethnicity and HIV/AIDs among injection
drug users. Results: Results demonstrated a positive relationship between
injection drug use and HIV/AIDs as well as a positive relationship between
HIV/AIDs and involvement in a needle exchange program. Race/ethnicity was
not associated with HIV/AIDs among injection drug users. Conclusion: The
results of the study highlight the need to further research injection drug users and
how they may be at increased risk for blood-borne diseases such as HIV/AIDs. In
addition, the results emphasize the importance of needle exchange programs as
they may be the only source of care for injection drug users.
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CHAPTER ONE
INTRODUCTION

Problem Statement
Drug use is a complex behavior with multidimensional determinants,
including social, psychological, cultural, economic, and biological factors. (Edlin,
2005) Substance use is one of the concerning major public health issues as
substances can be misused and this use can ultimately lead to blood borne
disease transmission due to poor health practices.
The 2002 National Survey on Drug Use and Health reported that 3.7
million Americans > 12 years have experimented with heroin use. (Edlin, 2005)
An estimated 1.0-1.5 million Americans actively use illicit drugs by injection.
(Edlin 2005) Substance use increases the likelihood individuals will contract
blood-borne viral infections. Infections are transmitted when uninfected injection
drug users (IDUs) use injection equipment, especially syringes, that have
previously been used by an infected person. (Edlin, 2005)
In response to the HIV epidemic and overdose among IDUs, needle
exchange programs provide necessary resources to IDUs by reducing the health
and social harms associated with injection drug use. (Kerr, 2007) Among
injection drug users (IDUs), high levels of HIV risk-associated behavior at the
time of initiation of injection drug use has been reported: 213 (20%) participants
reported their first injection was performed with a used syringe, and 796 (75%)
participants reported they were injected by someone else during their first
1

injection. (Kerr, 2007) Illicit drug injection is a serious public health issue. Such
empirical evidence highlights IDUs first injection experience as an act of risky
behavior. There is a need for interventions to prevent initiation of injection drug
use and programs that promote safer injecting practices among new injectors.
(Kerr, 2007) More specifically, programs and interventions that assist with first
time IDUs and current IDUs should focus on preventing addiction and bloodborne diseases in the future. Overall, the main goals of these programs should
be to prevent the initiation of injection drug use and promote safer injecting
practices. (Kerr, 2007). Substance use has led to disease transmission and
substance use disorders. Although needle exchange programs can be
controversial, findings indicate these programs can be beneficial. Needle
exchange programs can be controversial because there are concerns of
encouraging injection drug use. (Harris, 2016) However, research shows that
needle exchange programs are beneficial because they allow IDUs to shoot
(inject drugs intravenously), within a safe facility. (Kerr, 2007) The clinic provides
drug paraphernalia (water, filters, spoons) to practice safe sterile preparation for
individuals to safely inject drugs and prevent blood-borne disease transmission.
Aside from providing sterile drug paraphernalia the clinic allows IDUs to receive
effective care and treatment with health education. The information provided from
scholarly articles indicate how needle exchange programs promote health
education to individuals about disease transmission, provide helpful resources to
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help individuals maintain the behavior change going forward, prevent relapse,
and have the ability to seek help if relapse occurs.

Purpose of Study
The purpose of this study is to assess the prevalence of blood-borne
diseases among IDUs as well as the role of needle exchange programs to help
eliminate the epidemic of HIV infections among IDUs.
Research Questions
1. Do IDUs have a higher risk of blood-borne diseases compared to those
that do not inject drugs?
2. Do IDUs that participate in needle exchange programs have a lower risk of
contracting blood-borne diseases compared to IDUs who do not
participate in needle exchange programs?
3. Does the prevalence of blood-borne diseases among IDUs vary by
race/ethnicity?

Significance to Public Health
Substance use is a relevant topic in the field of public health in order to
prevent morbidity and mortality. Evaluating the role of needle exchange
programs is critical to address the needs of IDUs, such as providing adequate
resources to IDUs to understand their options for medical and psychological help,
and ultimately preventing disease transmission from occurring.
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The proposed thesis will meet several public health accreditation
standards. Selected data from appropriate scholarly journals. This method will
collect the data from educational resources and statistical data collected from
publicly available de-identified data collection through the 2019 National Survey
on Drug Use and Health (NSDUH). First, selecting quantitative and qualitative
data collection methods appropriate for a given public health context. This
standard will be met by using publicly available de-identified data collection
through the 2019 National Survey on Drug Use and Health (NSDUH). Second,
analyzing quantitative and qualitative data using biostatistics, informatics,
computer-based programming, and software, as appropriate. This standard will
be met by assessing the relationships between the variables of interest using
SPSS to carry out the analyses. Third, interpreting results of data analysis for
public health research, policy, or practice. This standard will be met by
discussing the results of the study findings in the written thesis and oral defense.
Fourth, the communication of appropriate public health content through writing
and defending the thesis to a professional audience will meet this standard.
Overall, these standards will be achieved by integrating knowledge from multiple
scholarly sources along with the present study. Ultimately, the present study has
the potential to support health education initiatives that address substance use
within needle exchange programs among IDUs.
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CHAPTER TWO
LITERATURE REVIEW

What are Health outcomes and Structural Interventions of NEPs
Needle exchange programs (NEPs) also referred as syringe exchange
programs (SEPs) provide services to injection drug users (IDUs) such as
substance use treatments, health screenings, medical care, and educational
resources for safer injection practices to decrease HIV infection rates. Injection
drug use is one of the most efficient modes of transmission of human
immunodeficiency virus (HIV) and other blood-borne diseases. (Abdul-Quader,
2013). Injection drug users are at high risk for blood-borne diseases as they
engage in risky behaviors such as sharing injection equipment and drug supplies.
(Abdul-Quader, 2013). Needle exchange programs provide the opportunity for
drug users to decrease infection rates and encourage sobriety. Compelling
evidence increases that the availability and utilization of sterile equipment given
among IDUs, helps reduce HIV infection rates. These programs are in place to
provide sterile needles, syringes, and additional paraphernalia to IDUs and
protect IDUs as a whole. The purpose of this literature review is to provide a
summary of the current literature on needle exchange programs.
What is a Needle Exchange Program?
Needle exchange programs are community-based prevention programs
that provide a range of resources and medical services. Needle exchange
programs have been implemented in cities, regions, and countries worldwide to
5

address HIV and hepatitis infection among IDUs. (Abdul-Quader, 2013) These
programs provide safe needle disposal, emergency overdose response, HIV and
Hepatitis testing including bacterial and fungal treatments, vaccines, drug
detoxification, counseling, health education, and sterile syringe distribution. They
have been shown to be beneficial in reducing risky behaviors and factors that
influence virus transmission. (Abdul-Quader, 2013). Drug and virus transmission
can affect any person of any age, race/ethnicity, and social status, but this public
health issue can be tackled with the implementation of needle exchange
programs to fight against substance abuse and blood-borne diseases among
individuals who inject drugs. These needle exchange programs are safe,
effective, and cost-saving, do not increase illegal drug use or crime among drug
users and the community, and play an important role in reducing the
transmission of viral blood-borne diseases such as HIV and Hepatitis. This is a
program that is used strategically within public health as an intervention for
possible harm reduction among injection drug users.
Health Outcomes of Injection Drug Users
Needle exchange programs are used to tackle the HIV epidemic among
injection drug users (IDUs). Needle exchange programs provide reliable
resources and consist of fixed-site specialist services to address the needs of
drug users. Services in needle exchange programs include HIV and HCV testing
and counseling, methadone maintenance treatment, drug detoxification services,
needle and syringe distribution, and health care related to infections associated
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with injection and substance abuse. (Abdul-Quader, 2013). These programs will
also include medical staff supervision for an emergency overdose response if
needed. Needle exchange programs may have the ability to lower blood-borne
infection rates among people who inject drugs and provide interventions to stop
drug use. The health consequences of people who inject drugs can be bloodborne diseases, mental health disorders, poverty, and homelessness. If IDUs
continue treatment within the program the risky behaviors such as needle sharing
may slowly decrease.
Not all injection drug users (IDUs) remain in the same circumstances
when they begin attending a needle exchange program. Some IDUs may
improve their behaviors, such as stopping injection drug use, or minimize the
harm done by drugs. For example, an evaluation of the Insite needle exchange
program showed that the program was meeting its objectives of reducing public
disorder, infectious disease transmission, and overdoses and was successfully
referring individuals to a range of external programs, including detoxification and
addiction treatment programs. (Kerr, 2017). Additionally, reducing the risk
behaviors of people who inject drugs who also visit structural level needlesyringe programs can have a partial “herd immunity” effect that can protect the
local injection drug use population as a whole. (Abdul- Quader, 2013). Needle
exchange programs may improve the health of IDUs and impact the health of the
community.
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Structural Interventions That Influence Needle Exchange Programs
(NEPs). Drug use and syringe sharing is not new, but the rate of syringe sharing
is different from previous years due to law changes in legislation. The law
Assembly Bill No. 2077 changed in 1992 to allow the legal sales of
needles/syringes and as a result syringe-sharing among people who inject drugs
(PWID) decreased significantly. (Abdul-Quader, 2013) Such laws, regulations,
and policies can influence injection drug users’ behaviors by addressing external
factors. External factors determine structural interventions. Structural
interventions include physical, social, cultural, organizational, community,
economic, legal and policy factors and promote or impede health. (AbdulQuader, 2013). Structural interventions focus on factors that influence risky
behaviors, which frame the implementation of needle exchange programs.
Structural interventions are defined as those interventions where changes in
policy and legal environment have facilitated an increased availability of sterile
syringes which subsequently led to population-level changes in HIV and
HCV/HBV prevalence or incidence. (Abdul-Quader, 2013). Needle exchange
programs are a framework of structured interventions that facilitate behaviors
with supporting injection drug users (IDUs). Needle exchange programs may be
beneficial to tackle this public health issue; however, these programs experience
a lack of resources/funding. Reforms are urgently needed to facilitate the
integration of assisted injection and safer smoking interventions into supervised
injection facilities (SIFs) and reduce challenges in access to these facilities
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stemming from gender, disability, and polysubstance use. (Kerr, 2017). If these
facilities are implemented, they may also decrease the stigma associated with
injecting drugs. Needle use stigma and discrimination act as barriers among
people who inject drugs in addition to certain characteristics such as gender,
homelessness, ethnic minority status, and migrant status. Needle exchange
programs will provide a safe place for IDUs.
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CHAPTER THREE
METHODS

Study Design
This study is based on a quantitative assessment of secondary data. The
original cross-sectional study collected data on demographics, substance use,
mental health, and other health variables among individuals over the age of 12.
Details on the study design have been published and explained elsewhere, such
as in the codebook. SAMHDA. 2019.

Data Source and Collection
The present study used 2019 data from the National Survey on Drug Use
and Health (NSDUH) conducted through the Substance Abuse and Mental
Health Services Administration (SAMHSA). The sample is largely diverse
representing Hispanic, White, African American, and Asian populations. The
present study is an annual survey of the civilian, noninstitutionalized population
of youths aged 12 to 17 and included the responses of adults or those over 18.
NSDUH included questions around drug use, blood-borne diseases,
needle exchange programs and individuals receiving or seeking treatment.
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Measures and Data Analysis
Dependent Variables
HIV/AIDS was assessed by asking respondents if they were told they
have HIV/AIDS. Respondents were asked and answers were: Yes or No.
Independent Variables
Injection drug use. Respondents were asked if in the past 12 months they
have ever utilized injection drugs. Answers were: Yes or No.
Needle exchange programs. Respondents were asked if they are currently
receiving treatment or counseling. Possible answers were: Yes or No.
Race/ethnicity is measured by individuals identifying themselves within
their race groups as listed 1-7. Racial/ethnic categories included: 1- White, 2African American, 3 - Native American, 4 - Pacific Islander, 5 - Asian, 6 - multiethnic and 7 - Hispanic. The categories provided the analysis of the prevalence
among IDUs race/ethnicity diagnosed with HIV/AIDS.
Analyses began with descriptive statistics. Bivariate associations were
assessed for Pearson correlations and linear regressions. Research question
one was analyzed using correlations. Research question two and three both
analyzed data by conducting linear regression.

Ethics
This study was done retrospectively. Secondary data was used from
existing data approved by the CSUSB Institutional Review Board.
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CHAPTER FOUR
RESULTS

The results of this study are divided in relation to each research question:

HIV Risk among Injection Drug Users (IDUs)
The first research question was: Do IDUs have a higher risk of bloodborne diseases compared to those that do not inject drugs? In order to address
this research question, the analyses focused on evaluating the relationship
between injection drug use and blood-borne diseases, specifically HIV/AIDs.
Table 1 shows the correlation between injection drug users and HIV/AIDS. The
Pearson correlation of 0.014 indicates there is a small correlation between
injection drug use and HIV/AIDS. Further, this relationship is significant at the
p=0.001 level.
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Table 1. Association Between HIV/AIDs and Injection Drug Use among US
Adults (Unweighted). National Survey on Drug Use and Health 2019

The Role of Needle Exchange Programs
The second research question was: Do IDUs that participate in needle
exchange programs have a lower risk of contracting blood-borne diseases
compared to IDUs who do not participate in needle exchange programs? In order
to address this research question, the analyses focused on evaluating the
relationship between participation in needle exchange programs and HIV/AIDs
among injection drug users. Table 2 shows the findings from conducting
regression analysis. There is a positive association between participation in a
needle exchange program and HIV. Further this relationship is significant at the
0.006 level.
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Table 2. Association Between Involvement in a Needle Exchange Program and
HIV/AIDs among US Adult Injection Drug Users (Unweighted). National Survey
on Drug Use and Health. 2019

Differences by Race/Ethnicity
Research question 3 states: Does the prevalence of blood-borne diseases
among IDUs vary by race/ethnicity? Analysis focused on assessing the
relationship between race/ethnicity and HIV among IDUs. Table 3 and Table 4
shows that race/ethnicity is not significantly associated with HIV/AIDs.

14

Table 3. Association Between Race/Ethnicity and HIV/AIDs among US Adult
Injection Drug Users Bar Graph. National Survey on Drug Use and Health. 2019
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Table 4. Association Between Race/Ethnicity and HIV/AIDs among US Adult
Injection Drug Users (unweighted). National Survey on Drug Use and Health.
2019
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CHAPTER FIVE
DISCUSSION
The purpose of this study was to investigate the relationship between
injection drug use, HIV/AIDs, needle exchange programs, and whether there are
disparities by race/ethnicity. The present study used data from the 2019 NSDUH.
There appears to be a small correlation between injection drug use and
HIV/AIDS as expected. HIV infections are transmitted when uninfected injection
drug users (IDUs) use injection equipment, especially syringes, that have
previously been used by an infected person. (Edlin, 2005) Studies have shown
uninfected IDUs generally become infected at rates of 10%-20% per year. (Edlin,
2005) This is consistent with the literature that shows injection drug users are at
higher risk of blood-borne diseases. However, there was a positive association
between participation in a needle exchange program and HIV/AIDS. This is
contrary to what was expected. The purpose of needle exchange programs is to
enhance the understanding of injection drug use, blood-borne diseases, risky
behaviors, and substance use thus preventing HIV/AIDS. However, it is possible
that participation in a needle exchange program increased access to health
services which allowed IDUs to get tested for HIV/AIDS. It is possible that IDUs
that did not participate in needle exchange programs did not have access to
health care services thus many may have been undiagnosed. Lastly, there did
not appear to be any differences by race/ethnicity in the relationship between
injection drug use and HIV/AIDS. The impact of inject drug use on HIV/AIDS
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appears to cut across all racial/ethnic groups, but very much across the white
community. Despite this, disparities in access to services persist.
Notwithstanding the limitations, the use of the data to report risk for HIV among a
sample of IDUs is a major strength of our study and makes a contribution to our
understanding of racial disparities in HIV and needle exchange programs.
Greater HIV prevalence in minority networks and neighborhoods means that
risky behavior could result in transmission. Where people are located in relation
to the risk and resources that surround them is an important aspect of
understanding the effects of the environment on health and behavior (Williams,
2010). Certain geographic regions where communities are built are the areas
where there is a concentration of liquor stores, crime, violence, and drug use.
The results of this study emphasize the importance of needle exchange
programs particularly given the difference they can make to help decrease
substance use and reduce HIV/AIDs transmission among IDUs to help eliminate
this public health issue. Several benefits of needle exchange programs include
helping to reduce HIV transmission, providing IDUs with treatment and supplying
clean needles. Aside from providing treatment and supplies, needle exchange
programs may help reduce or abolish income inequalities, racism, and other
inequities to help eliminate this public health issue of substance use and bloodborne diseases among IDUs. (Lancaster, 2020). Of particular importance is
access to health care services. As previously mentioned, it was expected that
involvement in a needle exchange program would be negatively associated with
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HIV/AIDs. Needle exchange programs may be IDUs only source of care given
the stigma and discrimination they face. In 2021, the Biden administration
released a model law (model syringe services program act) to help states ensure
access to Needle exchange programs. Needle exchange programs through this
new law are part of the efforts to reduce overdoses, HIV, as well as helping IDUs
in accessing addiction treatments. (Knopf, 2021) IDUs who are not in these
programs represent a vulnerable group. These individuals are the ones who are
homeless, that are completely stigmatized and cut off from society and are not
properly diagnosed or being treated. Homeless individuals likely do not have
health insurance, given additional barriers to receiving health services and they
may not know if they have HIV/AIDS. This law provides states with a framework
to make sure syringe service programs are available wherever they are needed.
(Knopf, 2021) We should consider the services needle exchange programs
provide IDUs. Reducing new HIV infections will require translating evidencebased approaches to alleviate the risks associated with sharing injection
equipment. (Lancaster, 2020). But we have the issue that the results of this study
emphasize the importance of needle exchange programs and the support they
provide to IDUs. The data aligned with the literature that supports the
effectiveness of needle exchange programs and their immense impact among
IDUs and the community.
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Strengths and Limitations
This study has some strengths and limitations. The limitations in the
race/ethnicity population included samples being low due to the coefficient being
negative and cross-sectional data cannot prove causality. The HIV diagnosis is
something that can impact all races/ethnicities. There are certain groups that are
particularly stigmatized. There are certain groups that have a higher prevalence
of HIV/AIDS that are criminalized with drug use and have these culturally
competent barriers from being able to access treatment programs but based on
the data there wasn't any difference. Regardless of these limitations there are a
lot of values and strengths in my analysis. This is a nationwide survey where
there was a large number of respondents, so I was able to do a comprehensive
analysis. With this being said the data found may be used as an external tool for
further studies. Nevertheless, there are several strengths of this study. Both
variables HIV and injection drug use in this study data exposed the multiple
forms of drug use and the health risks IDUs are exposed to if not provided
treatment within needle exchange programs. The focus group of IDUs included
analyzing the relationship between drug treatment and race/ethnical groups.
Although, there was a strong relationship between IDUs receiving drug
treatment, but a weak relationship among the sample population based on race
and ethnicity.
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Recommendations for Research and Practice
The present study emphasized the need to focus on IDUs and consider
the role of needle exchange programs. Future studies should aim to get a better
sense of how needle exchange programs are being utilized among IDUs. This
understanding could help tailor programs that increase reach, reduce stigma, and
improve awareness of HIV infections among IDUs (Lancaster,2020). Public
health or medical agencies should consider innovative designs that account for
the heterogeneity in needs and preferences among IDUs (Lancaster,2020). For
example, programs should consider the healthcare services that people have
access to as there are major barriers in this country. It is possible that for many
IDUs needle exchange programs may be their only source of care. Additionally,
while the present study did not find evidence of racial/ethnic disparities, future
studies should continue to assess differences by race/ethnicity.

Conclusion
T The study's results indicate that IDUs may have a greater risk of
HIV/AIDs. If IDUs receive treatment by attending needle exchange programs this
can increase their knowledge of safe drug use. Evidently, it is essential IDUs are
able to practice safe drug injection use as well as receive education on bloodborne disease risks, mental illness, disparities, and decrease drug consumption.
The study literature and variables confirmed that needle exchange programs play
a role in health education and access to health care services and reveal how
different races/ethnicities can be negatively impacted. This represents a
21

challenge and opportunity; public health and needle exchange programs need to
ensure they are putting forth effective strategies to educate the community and
IDUs on this issue.
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